Controlled release pilocarpine delivery system
US5661171A · kind A · utility
5Cited by
11References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 2, 1995 |
| Grant date | Aug 26, 1997 |
| Priority date | — |
| Expiry date | May 2, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed a method for treating a patient suffering from xerostomia, xerophthaimia or excessive intraocular pressure. The method comprises administering to said patient a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof, in an amount sufficient to maintain a blood serum level of pilocarpine in said patient of from about 5 to about 40 ng/ml, for a period of at least 6 hours. Controlled release unit dosage forms containing pilocarpine are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.